Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparative Evaluation of DMF Scores in Patients Using Bisphosphonates: A Retrospective Study

View through CrossRef
Objectives This study aimed to evaluate the association between bisphosphonate use and the prevalence of dental caries in comparison with systemically healthy controls. Material and Methods This retrospective study included 100 patients: 50 were on bisphosphonate medication and 50 were healthy controls who were matched for age and gender. Between 2013 and 2023, each participant was recorded in the database of Akdeniz University's Faculty of Dentistry. Dental health markers, such as the number of undamaged teeth, restorations, and the prevalence of caries, were evaluated using panoramic radiography. The analysis did not include third molars. Following established standards, two skilled dentists independently assessed the radiographs. Patients between the ages of 18 and 70 were included in the inclusion criteria, however those with major radiographic artifacts, crowns, implants, or tooth loss were excluded. The end measures included the DMF index, the number of caries-affected teeth, the number of teeth that were treated, and the number of teeth that were fully intact. To use the independent samples t-test for statistical analysis, these parameters were compared between the bisphosphonate and control groups (P < 0.05). Results There was no statistically significant difference between the groups (p = 0.26), with the mean DMF index for healthy people being 8.42 and for bisphosphonate users being 9.32. The number of restored teeth (3.0 vs. 2.4, respectively; p = 0.08), carious teeth (2.08 vs. 2.34, respectively; p = 0.52), and sound teeth (20.12 vs. 20.32, respectively; p = 0.59) did not differ significantly either. Conclusion The DMF index, the number of sound teeth, restored teeth, and carious teeth did not differ statistically significantly between bisphosphonate users and healthy people. The DMF index did not significantly rise among bisphosphonate users. It is advised that bigger sample sizes be used in future research to validate these results.
Title: Comparative Evaluation of DMF Scores in Patients Using Bisphosphonates: A Retrospective Study
Description:
Objectives This study aimed to evaluate the association between bisphosphonate use and the prevalence of dental caries in comparison with systemically healthy controls.
Material and Methods This retrospective study included 100 patients: 50 were on bisphosphonate medication and 50 were healthy controls who were matched for age and gender.
Between 2013 and 2023, each participant was recorded in the database of Akdeniz University's Faculty of Dentistry.
Dental health markers, such as the number of undamaged teeth, restorations, and the prevalence of caries, were evaluated using panoramic radiography.
The analysis did not include third molars.
Following established standards, two skilled dentists independently assessed the radiographs.
Patients between the ages of 18 and 70 were included in the inclusion criteria, however those with major radiographic artifacts, crowns, implants, or tooth loss were excluded.
The end measures included the DMF index, the number of caries-affected teeth, the number of teeth that were treated, and the number of teeth that were fully intact.
To use the independent samples t-test for statistical analysis, these parameters were compared between the bisphosphonate and control groups (P < 0.
05).
Results There was no statistically significant difference between the groups (p = 0.
26), with the mean DMF index for healthy people being 8.
42 and for bisphosphonate users being 9.
32.
The number of restored teeth (3.
0 vs.
2.
4, respectively; p = 0.
08), carious teeth (2.
08 vs.
2.
34, respectively; p = 0.
52), and sound teeth (20.
12 vs.
20.
32, respectively; p = 0.
59) did not differ significantly either.
Conclusion The DMF index, the number of sound teeth, restored teeth, and carious teeth did not differ statistically significantly between bisphosphonate users and healthy people.
The DMF index did not significantly rise among bisphosphonate users.
It is advised that bigger sample sizes be used in future research to validate these results.

Related Results

Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Dental caries in HIV-infected children in Ho Chi Minh City
Dental caries in HIV-infected children in Ho Chi Minh City
Objectives: Children living with HIV are at elevated risk for oral diseases, including dental caries, due to immunocompromise, long-term antiretroviral therapy,...
Effect of bisphosphonates on bone giant cell tumor recurrence: a meta-analysis
Effect of bisphosphonates on bone giant cell tumor recurrence: a meta-analysis
Abstract Background We examined the impact of bisphosphonates as adjuvant therapy on the recurrence of giant cell bone tumors and the impact of vari...
Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
Purpose Bisphosphonates are commonly used for the treatment of osteoporosis and for prevention and treatment of skeletal lesions due to malignancy. However, the association between...
Descriptive Analysis of Patients Treated with Diroximel Fumarate and Dimethyl Fumarate. A Real-Life Experience
Descriptive Analysis of Patients Treated with Diroximel Fumarate and Dimethyl Fumarate. A Real-Life Experience
Dimethyl fumarate (DMF) and diroximel fumarate (DRF) are two treatments used in multiple sclerosis (MS), that have been shown to be effective in controlling MS patients. DRF was in...
Descriptive Analysis of Patients Treated with Diroximel Fumarate and Dimethyl Fumarate—A Real-Life Experience
Descriptive Analysis of Patients Treated with Diroximel Fumarate and Dimethyl Fumarate—A Real-Life Experience
Background: Dimethyl fumarate (DMF) and diroximel fumarate (DRF) are two treatments used for multiple sclerosis (MS) that have been shown to be effective in controlling MS patients...
Concentration‐dependent surface‐enhanced Raman scattering and molecular dynamic study of dimethyl formamide
Concentration‐dependent surface‐enhanced Raman scattering and molecular dynamic study of dimethyl formamide
AbstractA concentration‐dependent Raman study of dimethyl formamide (DMF) in Ag nanocolloidal solution was carried out in order to observe the effect of concentration on the surfac...

Back to Top